BSE Live
Apr 17, 16:01Prev. Close
30.87
Open Price
31.97
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
11.00
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Medi-Caps (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 2.37 | 6.93 | 0.00 | 0.00 | 0.00 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 2.37 | 6.93 | 0.00 | 0.00 | 0.00 | |
| Total Operating Revenues | 2.42 | 7.17 | 0.10 | 0.00 | 0.00 | |
| Other Income | 0.56 | 0.15 | 0.64 | 0.61 | 0.00 | |
| Total Revenue | 2.98 | 7.31 | 0.75 | 0.61 | 0.00 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Employee Benefit Expenses | 1.81 | 0.83 | 0.23 | 0.45 | 0.00 | |
| Finance Costs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 0.16 | 0.16 | 0.09 | 0.09 | 0.00 | |
| Other Expenses | 0.72 | 1.48 | 0.17 | 0.12 | 0.00 | |
| Total Expenses | 2.69 | 2.49 | 0.49 | 0.67 | 0.00 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.29 | 4.83 | 0.26 | -0.06 | 0.00 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 0.29 | 4.83 | 0.26 | -0.06 | 0.00 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.95 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.01 | -0.01 | 0.00 | 0.01 | -0.01 | |
| Tax For Earlier Years | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -0.27 | 0.94 | 0.00 | 0.01 | -0.01 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.56 | 3.89 | 0.26 | -0.08 | 0.01 | |
| Profit/Loss From Continuing Operations | 0.56 | 3.89 | 0.26 | -0.08 | 0.01 | |
| Profit/Loss For The Period | 0.56 | 3.89 | 0.15 | -0.04 | -0.11 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 0.45 | 3.12 | 0.12 | -0.03 | -0.09 | |
| Diluted EPS (Rs.) | 0.45 | 3.12 | 0.12 | -0.03 | -0.09 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
25.02.2026
Medi-Caps Consolidated December 2025 Net Sales at Rs 4.30 crore, up 6.87% Y-o-Y
25.02.2026
Medi-Caps Standalone December 2025 Net Sales at Rs 0.77 crore, up 196.77% Y-o-Y
19.11.2025
Medi-Caps Consolidated September 2025 Net Sales at Rs 2.01 crore, down 75.75% Y-o-Y
18.11.2025
Medi-Caps Standalone September 2025 Net Sales at Rs 1.00 crore, up 2.5% Y-o-Y
25.02.2026
Medi-Caps Consolidated December 2025 Net Sales at Rs 4.30 crore, up 6.87% Y-o-Y
25.02.2026
Medi-Caps Standalone December 2025 Net Sales at Rs 0.77 crore, up 196.77% Y-o-Y
19.11.2025
Medi-Caps Consolidated September 2025 Net Sales at Rs 2.01 crore, down 75.75% Y-o-Y
18.11.2025
Medi-Caps Standalone September 2025 Net Sales at Rs 1.00 crore, up 2.5% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth